Compare OFLX & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OFLX | IMRX |
|---|---|---|
| Founded | 1975 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.0M | 322.8M |
| IPO Year | 2005 | 2021 |
| Metric | OFLX | IMRX |
|---|---|---|
| Price | $29.01 | $5.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.20 |
| AVG Volume (30 Days) | 31.8K | ★ 639.7K |
| Earning Date | 06-12-2026 | 06-10-2026 |
| Dividend Yield | ★ 4.55% | N/A |
| EPS Growth | N/A | ★ 37.75 |
| EPS | ★ 1.13 | N/A |
| Revenue | ★ $101,681,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $26.50 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.58 | $1.10 |
| 52 Week High | $41.74 | $10.08 |
| Indicator | OFLX | IMRX |
|---|---|---|
| Relative Strength Index (RSI) | 29.81 | 59.70 |
| Support Level | $26.32 | $5.34 |
| Resistance Level | $29.54 | $7.67 |
| Average True Range (ATR) | 1.91 | 0.28 |
| MACD | -1.07 | 0.08 |
| Stochastic Oscillator | 22.16 | 81.57 |
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.